Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy-

Request For Quotation
Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy- Suppliers list
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy- manufacturers

  • COX-2-IN-23
  • COX-2-IN-23 pictures
  • $2500.00
  • 2026-04-21
  • CAS:2417995-08-3
  • Purity:
  • Supply Ability: 10g
Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy- Basic information
Product Name:Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy-
Synonyms:Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy-;COX-2-IN-23
CAS:2417995-08-3
MF:C24H25N5O3S2
MW:495.62
EINECS:
Product Categories:
Mol File:2417995-08-3.mol
Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy- Structure
Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy- Chemical Properties
Boiling point 651.3±65.0 °C(Predicted)
density 1.37±0.1 g/cm3(Predicted)
pka5.03±0.20(Predicted)
Safety Information
MSDS Information
Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy- Usage And Synthesis
UsesCOX-2-IN-23 (compound 9a) is a selective COX-2 inhibitor with IC50 values of 0.28 and 20.14 μM for COX-2 and COX-1. COX-2-IN-23 has anti-inflammatory activity and low ulcerogenic activity.
in vivo

COX-2-IN-23 (compound 9a) (9 mg/kg; a single i.p.; 0-4 hours) exhibits anti-inflammatory activities and lowest incidence of pepticulcer[1].

Animal Model:Mature male albino rats[1]
Dosage:9 mg/kg
Administration:Intraperitoneal injection; 0, 1, 2, 3 and 4 hours.
Result:Had similar ulcerogenic activity to celecoxib.
IC 50COX-2: 0.28 μM (IC50); COX-1: 20.14 μM (IC50)
References[1] Ibrahim TS, et al. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold. Bioorg Chem. 2020 Jul;100:103878. DOI:10.1016/j.bioorg.2020.103878
Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy- Preparation Products And Raw materials
Tag:Benzenesulfonamide, 3-(butylamino)-5-(4,5-dihydro-4-phenyl-5-thioxo-1H-1,2,4-triazol-3-yl)-2-phenoxy-(2417995-08-3) Related Product Information
Gallic acid GYY 4137 Morpholine salt Cianidanol Acetaminophen Salicylic acid Indometacin